1 / 17

Tetanus Toxoid

Tetanus Toxoid. MICS3 Data Analysis and Report Writing Workshop. International Goals & Targets. MDG 5: Reduce by three quarters the maternal mortality ratio Strategy: Elimination of maternal and neonatal tetanus

klarika
Download Presentation

Tetanus Toxoid

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tetanus Toxoid MICS3 Data Analysis and Report Writing Workshop

  2. International Goals & Targets MDG 5: Reduce by three quarters the maternal mortality ratio Strategy: Elimination of maternal and neonatal tetanus Target: Reduce incidence of neonatal tetanus to less than 1 case of neonatal tetanus per 1000 live births in every district

  3. International Goals & Targets By 2005, Reduction in infant and under-five mortality rate by at least 1/3, in pursuit of the goal of reducing it by 2/3 by 2015 Eliminate maternal and neonatal tetanus by 2005

  4. Background Caused by tetanus spores, a bacteria found everywhere in the environment Transmission occurs when there is contact with broken skin such as an infant’s umbilical cord Poverty, poor hygiene and limited access to health services increase the risk for transmission during childbirth

  5. Background Prevention is possible by: 1. Immunization of pregnant women with at least 2 doses of tetanus toxoid vaccine (TT2+), passing protection to the newborn for up to first two months of life 2. Immunization of women of childbearing age who live in areas of high risk for transmission (delivery of immunizations usually through campaigns) 3. Promotion of clean delivery and cord care practices

  6. Background

  7. Situation of Maternal and Neonatal Tetanus(Remains a problem in 48 countries) Neonatal Tetanus death reduction 248,000 200,000 180,000 MNT not eliminated Countries with TT campigns MNT eliminated * includes Timor-Leste Note: The boundaries and the names shown and the designations used on these maps do not imply official endorsement or acceptance by the United Nations.

  8. Indicator

  9. Methodological issues Data collected for all births during the 2 years before the survey – indicator includes only those during the last one year Complex algorithm for the estimation of the numerator

  10. Methodological issues two TT doses during the pregnancy (TT3>=2) one TT dose during the pregnancy and at least one TT dose prior to the pregnancy (TT3=1 AND TT6>=1) at least two TT doses prior to the pregnancy of which the last dose was less than 3 years before the birth with 3 doses within the 5 years before the pregnancy with 4 doses with the last dose less than 10 years before the pregnancy with 5 doses or more ever (TT6>=5).

  11. Country data – CEE/CIS Turkey 41% Neonatal tetanus protection (%), 2004

  12. Country data – Eastern and Southern Africa Neonatal tetanus protection (%),2004

  13. Country data – West and Central Africa Neonatal tetanus protection (%), 2004

  14. Country data – MENA Neonatal tetanus protection (%), 2004

  15. Country data – LAC Haiti 52% Neonatal tetanus protection (%), 2004

  16. Country data – South Asia Neonatal tetanus protection (%), 2004

  17. Country data – East Asia and the Pacific Neonatal tetanus protection (%), 2004

More Related